Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-27

Clinical Trial Update: Meditoxin® Treatment in Patients With Cervical Dystonia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Meditoxin treatment in cervical dystonia showing completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Meditoxin (botulinum toxin type A)

Snippet

Sponsor: Medy-Tox | Conditions: Dystonia, Dystonic Disorder | Phase 3 | Status: COMPLETED